Back to results
US 8,076,333 B2Granted
Fast acting naratriptan composition
AssigneeEmisphere Technologies, Inc.
InventorCristina Castelli
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions containing Naratriptan, a compound selected from the group consisting of 2-HPOD, 2-HPHM, 4-PPED, 4-BPED and 2-PPED, and optionally, a pharmaceutically acceptable excipient.
Claims23
A pharmaceutical composition comprising:
- (a) naratriptan or a salt thereof,
- (b) at least one compound selected from 8-(2-hydroxyphenoxy)octyldiethanolamine, 6-(2-hydroxyphenoxy)hexylmorpholine, 2-(4-phenoxyphenyl)ethyldiethanolamine, 2-(biphen-4-yl)ethyldiethanolamine, and pharmaceutically acceptable salts thereof;
- and
- (c) optionally, a pharmaceutically acceptable excipient,
- wherein the pharmaceutical composition, when administered orally, has a shortened time for the onset of maximum peak concentration (Tmax) compared to naratriptan alone.
2 more elements
Dependencies are inferred from the claim text.